Shelton Capital Management Castle Biosciences Inc Transaction History
Shelton Capital Management
- $4.17 Billion
- Q1 2025
A detailed history of Shelton Capital Management transactions in Castle Biosciences Inc stock. As of the latest transaction made, Shelton Capital Management holds 164,008 shares of CSTL stock, worth $3.34 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
164,008
Previous 164,008
-0.0%
Holding current value
$3.34 Million
Previous $4.37 Million
24.87%
% of portfolio
0.08%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
190Shares Held
26.7MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$41.7 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$29.9 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$25.7 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$24.4 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $535M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...